CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 185 enrolled
Drug / intervention
doripenemdrug
Likely dose
doripenem 1gfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00502801
NCT00502801Phase 2Completed
CompareCT.gov

A Phase 2 Study of Doripenem In The Treatment of Nosocomial and Ventilator-Associated Pneumonia In Hospitals

PriCara, Unit of Ortho-McNeil, Inc.·interventional·Posted Jul 18, 2007·Updated Sep 25, 2013

In Brief

A Phase 2 clinical trial evaluating doripenem for Pneumonia and 3 related conditions. Completed, enrolled 185 participants across 40 sites in 9 countries.

Detailed Summary

The purpose of this study is to evaluate the effectiveness and safety of doripenem monohydrate in the treatment of patients with nosocomial (hospital-acquired) pneumonia.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPneumonia, Bacterial Pneumonia, Ventilator-Associated Pneumonia, Infections, Nosocomial
CountriesArgentina, Canada, Chile, Croatia, France, India, Russia, Ukraine, United States
Collaborators--

Timeline

Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 18, 2007
Enrollment StartAug 1, 2007
Primary CompletionNov 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 19.0 years ago

Interventions

doripenemdrug

1g i.v. infused over 4 hours every 8 hours for 8 to 14 days